BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11781303)

  • 1. Elimination of Helicobacter pylori or acid in high-risk users of aspirin or nonsteroidal medications: final answer?
    Peek RM
    Gastroenterology; 2002 Jan; 122(1):238-40. PubMed ID: 11781303
    [No Abstract]   [Full Text] [Related]  

  • 2. H. pylori and risk of ulcer bleeding among users of NSAIDS.
    Atherton JC; Wight NJ
    Gastroenterology; 2000 Feb; 118(2):451-2. PubMed ID: 10691374
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gastrointestinal complications of nonsteroidal anti-inflammatory drugs and low-dose aspirin].
    Thiéfin G
    Gastroenterol Clin Biol; 2003 May; 27(5):498-510. PubMed ID: 12843912
    [No Abstract]   [Full Text] [Related]  

  • 4. Gastrointestinal bleeding associated with low-dose aspirin use: relevance and management in clinical practice.
    Lanas A
    Expert Opin Drug Saf; 2011 Jan; 10(1):45-54. PubMed ID: 20645883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of Helicobacter pylori infection and low-dose aspirin in the upper gastrointestinal tract: implications for clinical practice.
    Leung Ki EL; Chan FK
    Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):163-72. PubMed ID: 22542154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review: Helicobacter pylori and the risk of upper gastrointestinal bleeding risk in patients taking aspirin.
    Fletcher EH; Johnston DE; Fisher CR; Koerner RJ; Newton JL; Gray CS
    Aliment Pharmacol Ther; 2010 Oct; 32(7):831-9. PubMed ID: 20659284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-steroidal anti-inflammatory drugs and gastrointestinal damage-problems and solutions.
    Russell RI
    Postgrad Med J; 2001 Feb; 77(904):82-8. PubMed ID: 11161072
    [No Abstract]   [Full Text] [Related]  

  • 8. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study.
    Aalykke C; Lauritsen JM; Hallas J; Reinholdt S; Krogfelt K; Lauritsen K
    Gastroenterology; 1999 Jun; 116(6):1305-9. PubMed ID: 10348813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for upper gastrointestinal bleeding among aspirin users: An old issue with new findings from a population-based cohort study.
    Luo PJ; Lin XH; Lin CC; Luo JC; Hu HY; Ting PH; Hou MC
    J Formos Med Assoc; 2019 May; 118(5):939-944. PubMed ID: 30366771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of Helicobacter pylori in drug-induced gastrointestinal bleeding].
    Chaussade S; Abitbol V
    Presse Med; 2003 Nov; 32(37 Pt 2):S60-3. PubMed ID: 14763358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin.
    Lanas A; Fuentes J; Benito R; Serrano P; Bajador E; Sáinz R
    Aliment Pharmacol Ther; 2002 Apr; 16(4):779-86. PubMed ID: 11929396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: synergy or null effect?
    Am J Manag Care; 2001 Sep; 7(12 Suppl):S402-3. PubMed ID: 11570032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiplatelet drugs and gastrointestinal bleeding: numquam periclum sine periclo vincitur].
    Rossini R; Lucà MG; Scuri P; Invernizzi P; Strazzabosco M; Gavazzi A
    Ital Heart J Suppl; 2005 Oct; 6(10):621-6. PubMed ID: 16273749
    [No Abstract]   [Full Text] [Related]  

  • 14. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.
    Chan FK; Chung SC; Suen BY; Lee YT; Leung WK; Leung VK; Wu JC; Lau JY; Hui Y; Lai MS; Chan HL; Sung JJ
    N Engl J Med; 2001 Mar; 344(13):967-73. PubMed ID: 11274623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Should Helicobacter pylori infection be tested and eradicated in patients treated or about to be treated with aspirin or nonsteroidal anti-inflammatory drugs?].
    Thiéfin G
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):415-26. PubMed ID: 12700498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
    Chan FK
    Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commentary: bleeding ulcers, interaction between NSAIDs and Helicobacter pylori infection, and nonulcer dyspepsia.
    Veldhuyzen van Zanten SJ
    Gastroenterology; 1997 Dec; 113(6 Suppl):S90-2. PubMed ID: 9394767
    [No Abstract]   [Full Text] [Related]  

  • 18. Ulcer risk factors: interactions between Helicobacter pylori infection, nonsteroidal use, and age.
    Schubert TT; Bologna SD; Nensey Y; Schubert AB; Mascha EJ; Ma CK
    Am J Med; 1993 Apr; 94(4):413-8. PubMed ID: 8475935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upper GI risks of NSAIDs and antiplatelet agents: key issues for the cardiologist.
    Johnson DA
    Rev Cardiovasc Med; 2005; 6 Suppl 4():S15-22. PubMed ID: 17710072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans.
    Konturek JW; Dembinski A; Konturek SJ; Stachura J; Domschke W
    Gastroenterology; 1998 Feb; 114(2):245-55. PubMed ID: 9453483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.